Rafferty Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Buy |
75,108
+4,278
| +6% | +$1.9M | 0.11% | 103 |
|
|
2025
Q1 | $34.3M | Sell |
70,830
-19,389
| -21% | -$9.4M | 0.15% | 92 |
|
|
2024
Q4 | $36.3M | Buy |
90,219
+3,910
| +5% | +$1.57M | 0.13% | 96 |
|
|
2024
Q3 | $40.1M | Sell |
86,309
-6,816
| -7% | -$3.17M | 0.14% | 84 |
|
|
2024
Q2 | $43.6M | Buy |
93,125
+13,809
| +17% | +$6.47M | 0.16% | 73 |
|
|
2024
Q1 | $33.2M | Buy |
79,316
+1,084
| +1% | +$453K | 0.12% | 92 |
|
|
2023
Q4 | $31.8M | Buy |
78,232
+1,200
| +2% | +$488K | 0.13% | 95 |
|
|
2023
Q3 | $26.8M | Buy |
77,032
+6,650
| +9% | +$2.31M | 0.16% | 88 |
|
|
2023
Q2 | $24.8M | Buy |
70,382
+5,361
| +8% | +$1.89M | 0.14% | 93 |
|
|
2023
Q1 | $20.5M | Buy |
65,021
+1,469
| +2% | +$463K | 0.14% | 107 |
|
|
2022
Q4 | $18.4M | Buy |
63,552
+2,041
| +3% | +$589K | 0.15% | 108 |
|
|
2022
Q3 | $17.8M | Buy |
61,511
+14,629
| +31% | +$4.24M | 0.19% | 90 |
|
|
2022
Q2 | $13.2M | Sell |
46,882
-11,535
| -20% | -$3.25M | 0.12% | 97 |
|
|
2022
Q1 | $15.2M | Buy |
58,417
+3,982
| +7% | +$1.04M | 0.09% | 134 |
|
|
2021
Q4 | $12M | Buy |
54,435
+7,270
| +15% | +$1.6M | 0.06% | 160 |
|
|
2021
Q3 | $8.56M | Buy |
47,165
+8,019
| +20% | +$1.45M | 0.06% | 186 |
|
|
2021
Q2 | $7.89M | Buy |
39,146
+1,537
| +4% | +$310K | 0.05% | 223 |
|
|
2021
Q1 | $8.08M | Buy |
37,609
+12,588
| +50% | +$2.71M | 0.06% | 194 |
|
|
2020
Q4 | $5.91M | Sell |
25,021
-491
| -2% | -$116K | 0.06% | 186 |
|
|
2020
Q3 | $6.94M | Buy |
25,512
+4,286
| +20% | +$1.17M | 0.08% | 139 |
|
|
2020
Q2 | $6.16M | Buy |
21,226
+5,611
| +36% | +$1.63M | 0.09% | 138 |
|
|
2020
Q1 | $3.72M | Sell |
15,615
-21,600
| -58% | -$5.14M | 0.16% | 78 |
|
|
2019
Q4 | $8.15M | Sell |
37,215
-14,405
| -28% | -$3.15M | 0.13% | 93 |
|
|
2019
Q3 | $8.75M | Buy |
51,620
+9,885
| +24% | +$1.67M | 0.14% | 79 |
|
|
2019
Q2 | $7.65M | Buy |
41,735
+2,539
| +6% | +$466K | 0.13% | 92 |
|
|
2019
Q1 | $7.21M | Buy |
39,196
+29,602
| +309% | +$5.45M | 0.12% | 93 |
|
|
2018
Q4 | $1.59M | Sell |
9,594
-1,446
| -13% | -$240K | 0.03% | 280 |
|
|
2018
Q3 | $2.13M | Buy |
11,040
+47
| +0.4% | +$9.06K | 0.03% | 279 |
|
|
2018
Q2 | $1.87M | Buy |
10,993
+1,759
| +19% | +$299K | 0.03% | 306 |
|
|
2018
Q1 | $1.51M | Sell |
9,234
-863
| -9% | -$141K | 0.02% | 392 |
|
|
2017
Q4 | $1.51M | Sell |
10,097
-4,901
| -33% | -$734K | 0.03% | 315 |
|
|
2017
Q3 | $2.28M | Sell |
14,998
-2,940
| -16% | -$447K | 0.05% | 204 |
|
|
2017
Q2 | $2.31M | Buy |
17,938
+5,429
| +43% | +$700K | 0.07% | 193 |
|
|
2017
Q1 | $1.37M | Sell |
12,509
-601
| -5% | -$65.7K | 0.03% | 254 |
|
|
2016
Q4 | $966K | Buy |
13,110
+5,193
| +66% | +$383K | 0.04% | 232 |
|
|
2016
Q3 | $690K | Buy |
7,917
+1,140
| +17% | +$99.4K | 0.03% | 279 |
|
|
2016
Q2 | $583K | Sell |
6,777
-2,661
| -28% | -$229K | 0.04% | 336 |
|
|
2016
Q1 | $750K | Buy |
9,438
+2,114
| +29% | +$168K | 0.04% | 329 |
|
|
2015
Q4 | $926K | Buy |
7,324
+449
| +7% | +$56.8K | 0.11% | 212 |
|
|
2015
Q3 | $716K | Sell |
6,875
-394
| -5% | -$41K | 0.06% | 303 |
|
|
2015
Q2 | $898K | Buy |
7,269
+502
| +7% | +$62K | 0.06% | 245 |
|
|
2015
Q1 | $798K | Buy |
6,767
+2,447
| +57% | +$289K | 0.06% | 287 |
|
|
2014
Q4 | $513K | Buy |
4,320
+1,259
| +41% | +$150K | 0.12% | 192 |
|
|
2014
Q3 | $344K | Buy |
3,061
+566
| +23% | +$63.6K | 0.04% | 229 |
|
|
2014
Q2 | $236K | Sell |
2,495
-1,980
| -44% | -$187K | 0.05% | 285 |
|
|
2014
Q1 | $316K | Buy |
4,475
+839
| +23% | +$59.2K | 0.07% | 179 |
|
|
2013
Q4 | $270K | Buy |
+3,636
| New | +$270K | 0.06% | 203 |
|